Noulti-MD 4 Tablet
Marketer
Jaimcord Healthcare Pvt Ltd
Salt Composition
Ondansetron (4mg)
Overview Noulti-MD 4 Tablet
Quadramet 4mg tablets offer antiemetic relief, effectively managing nausea and vomiting stemming from various medical issues, including gastrointestinal distress. They are also prescribed to prevent nausea and vomiting associated with surgical procedures, cancer treatments (chemotherapy and radiotherapy). Quadramet 4mg may be administered independently or alongside other medications, with or without food. Dosage is determined by your physician based on your specific needs. The initial dose is typically administered prior to surgery, chemotherapy, or radiotherapy; subsequent doses, usually for a short duration (a few days), follow your doctor's instructions. Consistent daily intake at the same time(s) maximizes efficacy. Avoid exceeding the prescribed dosage. This medication does not address other cancer treatment side effects, and is minimally effective against motion sickness-induced vomiting. Common side effects include headache, diarrhea, constipation, and fatigue, typically resolving upon cessation. Persistent or bothersome side effects should be discussed with your doctor, who may offer mitigating strategies. Prior to commencing treatment, inform your doctor of any pre-existing cardiac or hepatic conditions, gastrointestinal obstructions, or concurrent medications, particularly those for epilepsy, heart conditions, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should consult their physician before use.
Primary Ingredients of Noulti-MD 4 Tablet
No information provided. Therefore, no text can be rewritten.
Uses of Noulti-MD 4 Tablet
Managing nausea and vomiting
Major Benefits of Noulti-MD 4 Tablet:
Administer this medication precisely as prescribed by your physician. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. Noulti-MD 4 Tablets can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Noulti-MD 4 Tablet:
- Fatigue
- Headache
- Constipation
- Diarrhea
How to use Noulti-MD 4 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from immediate swallowing. Noulti-MD 4 Tablets can be ingested with or without food, however, consistent timing is recommended.
How Noulti-MD 4 Tablet works:
Noulti-MD 4 tablets offer antiemetic relief. This medication's mechanism involves inhibiting serotonin, a neurotransmitter that can trigger nausea and vomiting associated with chemotherapy or post-surgical recovery.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Noulti-MD 4 Tablet requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on Noulti-MD 4 Tablet is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Noulti-MD 4 Tablet usage while breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Noulti-MD 4 Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Noulti-MD 4 Tablet is considered safe for individuals with kidney impairment; no dosage modification is typically necessary. Nevertheless, disclosure of pre-existing kidney disease to your physician is advisable. Data regarding the use of this medication beyond a single day remains limited.
LiverCONSULT YOUR DOCTOR
Data regarding Noulti-MD 4 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Noulti-MD 4 Tablet :
Should you forget a Noulti-MD 4 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Noulti-MD 4 Tablet
| Label | Value |
|---|---|
| Chemical Category | Carbazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |



